To access this element change to forms mode OFF
Grant Award View - GA289047
Repurposing approved drugs for Friedreich’s ataxia heart disease
GA ID:
GA289047
Agency:
Department of Health and Aged Care
Approval Date:
13-Dec-2022
Publish Date:
20-Mar-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 30-Jun-2025
Value (AUD):
$627,818.92
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Repurposing approved drugs for Friedreich’s ataxia heart disease
Purpose:
Friedreich's ataxia is a genetic disorder and heart disease is the leading cause of premature death in Friedreich’s ataxia patients. There is currently no treatment for Friedreich’s ataxia heart disease. Using a disease-in-a-dish model of Friedreich’s ataxia heart disease we will identify and repurpose safe, FDA-approved compounds (an approach that is faster than new drug development) that can prevent and reverse the symptoms of Friedreich’s ataxia heart disease and facilitate clinical trials.
GO ID:
GO Title:
MRFF - 2021 Early to Mid-Career Researchers Grant Opportunity
Internal Reference ID:
2022/MRF2023474
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
St Vincent's Institute of Medical Research
Recipient ABN:
52 004 705 640
Grant Recipient Location
Suburb:
Fitzroy
Town/City:
Fitzroy
Postcode:
3065
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA